Naproxen Sodium And Diphenhydramine Hcl Tablet, Film Coated
Product Images NDC 62207-814

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium And Diphenhydramine Hcl (NDC 62207-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton

This is a drug information sheet, providing information on a medication including dosage, active and inactive ingredients, possible side effects, and warnings. There is a phone number for questions or comments.*

FDA Label Image

Label

FDA Label Image

Nap-diphen-label1-jpg (Nap Diphen Label1 Jpg)

FDA Label Image

Nap-diphen-label2-jpg (Nap Diphen Label2 Jpg)

This is a description of Naproxen Sodium and Diphenhydramine Hydrochloride tablets, which contain 220mg of Naproxen Sodium USP and 25mg of Diphenhydramine Hydrochloride USP. The batch contains 7500 tablets with a manufacturing date (Mfg. Dt.) and expiration date (Exp.DL.), as well as a manufacturing license number (Mfg.Lic.No.). The NDC No. is 62207-814-39, and the storage temperature should be between 20°C to 25°C (68°F to 77°F). The tablets are made in India, with the FG code: 700000002498. The caution is for repacking only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.